NCT05532410 is a NA clinical trial of Fundus Camera in Retina Disease, sponsored by Optos, PLC.

Who is sponsoring NCT05532410?

NCT05532410 is sponsored by Optos, PLC.

What drugs are being tested in NCT05532410?

Interventions in NCT05532410: Fundus Camera.

What condition does NCT05532410 study?

NCT05532410 studies Retina Disease, Glaucoma, Normal.

Is NCT05532410 still recruiting?

NCT05532410 is currently completed. Last updated 7 December 2023.

Last reviewed 2023-12-07 · How we verify

NCT05532410

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Optic Disc Photograph Collection Study

Completed NA Last updated 7 December 2023

What this trial tests

NA trial testing Fundus Camera in Retina Disease in 121 participants. Completed in 21 March 2023.

Timeline

2 September 2022

Primary endpoint
21 March 2023

21 March 2023

Quick facts

Lead sponsor	Optos, PLC
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	121
Start date	2 September 2022
Primary completion	21 March 2023
Estimated completion	21 March 2023
Sites	1 location across United States

Drugs / interventions tested

Fundus Camera

Conditions studied

Retina Disease — all drugs for Retina Disease →
Glaucoma — all drugs for Glaucoma →
Normal — all drugs for Normal →

Sponsor

Optos, PLC

Who can join

22 and older, any sex, with Retina Disease or Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to collect stereo-optic disc photographs for potential future analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Optos, PLC trials

Trials by the same sponsor.

NCT07149740 — Data Gathering for A10900 · recruiting
NCT06305481 — Glaucoma Evaluation With the P200TE · NA · completed
NCT06269666 — P200TxE Diseased Eye Image Collection · NA · recruiting
NCT05844852 — P200TE US Reference Database Study · NA · active not recruiting
NCT05536401 — P200TE Agreement and Precision Study · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05532410 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Optos, PLC
Last refreshed: 7 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05532410.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing